THE CHRONIC DISEASE RESEARCH FOUNDATION
The CDRF, an independent medical research charity, funds a range of research programs that aim to discover the cause of common chronic diseases such as heart disease, arthritis, migraine, asthma, dementia. The CDRF runs many projects at the Department of Twin Research, St Thomas' Hospital. It is hoped the research will contribute to the development of future diagnostic tests and treatments.
Objects
THE PROMOTION OF RESEARCH INTO THE CAUSES OF, AND CURE FOR, CHRONIC DISEASES INCLUDING (BUT WITHOUT LIMITING THE GENERALITY OF THE FOREGOING) COMMON DISEASES THAT HAVE A STRONG GENETIC INFLUENCE; ANDSUCH OTHER CHARITABLE PURPOSES AS THE BOARD IN ITS ABSOLUTE DISCRETION FROM TIME TO TIME THINKS FIT.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a deficit of £732,638 for the year ended 5 April 2025, resulting in closing net assets of £5,112,615. The trustees' report confirms that unrestricted funds of £543,110 remain well above the stated policy minimum of approximately six months' projected management and administrative expenditure. The independent auditors confirmed that the use of the going concern basis of accounting is appropriate with no material uncertainties identified.
What the accounts disclose
“The Foundation’s primary income source is donations and bequests. For general purposes, the Foundation raised £1,101 (2024: £445) in donations from private donors and investment income of £62,542 (2024: £178,915).” — page 5
“The trustees’ policy regarding free reserves is to set a minimum for such reserves equal to approximately six months’ projected management and administrative expenditure.” — page 5
“During the year, £9,000 (2024: £2,880) was charged by Collyer Bristow for administration and other legal services. Mr M D B Simon, Trustee, is a partner of Collyer Bristow.” — page 26
“Expenditure in the year includes £234,225 (2024: £189,669) to projects of which Professor Tim Spector (Medical Director) is the lead researcher. A further £158,493 (2024: £1,035,248) has been approved for payment to projects led by Professor Spector.” — page 26
“During the year, £9,000 (2024: £2,880) was charged by Collyer Bristow for administration and other legal services. Mr M D B Simon, Trustee, is a partner of Collyer Bristow.” — page 26
“Expenditure in the year includes £234,225 (2024: £189,669) to projects of which Professor Tim Spector (Medical Director) is the lead researcher. A further £158,493 (2024: £1,035,248) has been approved for payment to projects led by Professor Spector.” — page 26
“During the year, £9,000 (2024: £2,880) was charged by Collyer Bristow for administration and other legal services. Mr M D B Simon, Trustee, is a partner of Collyer Bristow.” — page 26
“Expenditure in the year includes £234,225 (2024: £189,669) to projects of which Professor Tim Spector (Medical Director) is the lead researcher. A further £158,493 (2024: £1,035,248) has been approved for payment to projects led by Professor Spector.” — page 26
Policies the charity declares
- Complaints handling
- Complaints policy and procedures
- Conflicting interests
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Investing charity funds policy and procedures
- Investment
- Paying staff
- Risk management
- Safeguarding policy and procedures
- Safeguarding vulnerable beneficiaries
- Serious incident reporting policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
From the charity’s annual return (Part A, self-declared)
Self-declared on the annual return for the financial year ending 05/04/2025
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 05/04/2024
- Grant-making is its main activity
Self-declared on the annual return for the financial year ending 05/04/2023
- Grant-making is its main activity
Corporate structure
- Registered company of the charity Companies House 12266787
Company officers (Companies House)
- WALLEY, Andrew John, Dr on trustee list
- ROSS, Jonathan Mark Henry on trustee list
- BOCHUKOVA, Elena Georgieva, Dr on trustee list
- BENAIM, Michael on trustee list
- PIKE, Nicholas Simon on trustee list
- SIMON, Mark Daniel Benjamin on trustee list
Structured financials (annual return, FY ending 05/04/2024)
Register events
- Received assets from another charity (31/05/2023)
- Received assets from another charity (17/12/2020)
Trustees
- Mark Daniel Benjamin Simonchair
- Dr Elena Georgieva Bochukova
- Jonathan Ross
- MICHAEL BENAIM
- Nicholas Pike
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 05/04/2025 | £214k | £947k |
| 05/04/2024 | £4.4m | £1.4m |
| 05/04/2023 | £791k | £1.4m |
| 05/04/2022 | £481k | £1.8m |
| 05/04/2021 | £3.2m | £690k |
Common questions
Is THE CHRONIC DISEASE RESEARCH FOUNDATION financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a deficit of £732,638 for the year ended 5 April 2025, resulting in closing net assets of £5,112,615. The trustees' report confirms that unrestricted funds of £543,110 remain well above the stated policy minimum of approximately six months' projected management and administrative expenditure. The independent auditors confirmed that the use of the going concern basis of accounting is appropriate with no material uncertainties identified. Its FY2025 accounts were audited by Bourner Bullock.
Who funds THE CHRONIC DISEASE RESEARCH FOUNDATION?
Funders whose own accounts filings name THE CHRONIC DISEASE RESEARCH FOUNDATION as a grant recipient include DENISE COATES FOUNDATION, THE WYFOLD CHARITABLE TRUST.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| DENISE COATES FOUNDATION | FY2024 | £4.2m | To fund a 5-year Ageing Research project and to fund pilot projects, offering fellowships to appropriate candidates whilst supporting PhD students and related p |
| DENISE COATES FOUNDATION | FY2021 | £1.3m | A project researching how the Microbiome and Metabolome can affect Covid-19, along with long-term funding towards pilot projects, fellowships and PHD students |
| DENISE COATES FOUNDATION | FY2023 | £758k | Fund the Ageing Research 5 year project and support activities related to the study of the Microbiome and ageing. |
| THE WYFOLD CHARITABLE TRUST | FY2022 | £10k | The advancement of health or the saving of lives |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| THE LORNA AND YUTI CHERNAJOVSKY BIOMEDICAL RESEARCH FOUNDATION | 2 | £257k |
| WELLCOME TRUST | 1 | £161.9m |
| BRITISH HEART FOUNDATION | 1 | £3.9m |
| THE CHRIS BANTON FOUNDATION | 1 | £2.5m |
| THE ALDAMA FOUNDATION | 1 | £565k |
| Blood Cancer UK Research | 1 | £379k |
| THE STONEYGATE TRUST | 1 | £371k |
| PANCREATIC CANCER UK | 1 | £297k |
Charities like this
- THE FRANCIS CRICK INSTITUTE LIMITED
- THE CHRONIC GRANULOMATOUS DISORDER SOCIETY
- DIABETES RESEARCH & WELLNESS FOUNDATION
- MANCHESTER NEUROLOGICAL RESEARCH TRUST FUND
- DOWNS SYNDROME RESEARCH FOUNDATION LIMITED
- DEMENTIA RESEARCH UK
Side by side with its peers
| Charity | Income | Top pay band | Staff >£60k | Reserves vs policy | Fundraising cost | Going concern |
|---|---|---|---|---|---|---|
| THE CHRONIC DISEASE RESEARCH FOUNDATION | £214k | — | 0 | above | — | no doubt |
| THE FRANCIS CRICK INSTITUTE LIMITED | £246.2m | — | — | above | — | no doubt |
| THE CHRONIC GRANULOMATOUS DISORDER SOCIETY | £359k | — | 0 | within | 41.0% | no doubt |
| DIABETES RESEARCH & WELLNESS FOUNDATION | £1.3m | £60,001 - £70,000 | — | unclear | — | no doubt |
| MANCHESTER NEUROLOGICAL RESEARCH TRUST FUND | £33k | — | 0 | above | — | no doubt |
| DOWNS SYNDROME RESEARCH FOUNDATION LIMITED | £30k | — | — | unclear | — | no doubt |